AstraZeneca PLC Files 6-K for Q2 2025
Ticker: AZN · Form: 6-K · Filed: 2025-07-29T00:00:00.000Z
Sentiment: neutral
Topics: 6-K, quarterly-update, pharmaceuticals
Related Tickers: AZN
TL;DR
AZN Q2 2025 6-K filed: Updates on Wainua, Truqap, Beyfortus & more.
AI Summary
AstraZeneca PLC filed a 6-K report on July 29, 2025, for the period ending June 30, 2025. The filing includes information related to various product segments such as Wainua, VaccineAndInfection, Truqap, Tezspire, Saphnelo, Beyfortus, and Airsupra, with specific reporting periods from April 1, 2025, to June 30, 2025.
Why It Matters
This filing provides an update on AstraZeneca's performance and product-specific data for the second quarter of 2025, which is crucial for investors and analysts tracking the company's progress.
Risk Assessment
Risk Level: low — This is a routine 6-K filing providing operational updates and financial information, not indicating any immediate significant risks.
Key Players & Entities
- ASTRAZENECA PLC (company) — Filer
- 0000901832 (company) — Central Index Key
- 20250630 (date) — Period of Report
- 20250729 (date) — Filing Date
- Wainua (product) — Product Segment
- Truqap (product) — Product Segment
- Beyfortus (product) — Product Segment
FAQ
What is the reporting period for this 6-K filing?
The conformed period of report is June 30, 2025.
When was this 6-K filing submitted to the SEC?
The filing was submitted on July 29, 2025.
What is AstraZeneca PLC's Central Index Key (CIK)?
AstraZeneca PLC's CIK is 0000901832.
Which product segments are specifically mentioned in the filing for the period April 1, 2025, to June 30, 2025?
The filing mentions Wainua, VaccineAndInfection, Truqap, Tezspire, Saphnelo, Beyfortus, and Airsupra.
What is AstraZeneca's business address listed in the filing?
The business address is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA.
From the Filing
0001104659-25-071432.txt : 20250729 0001104659-25-071432.hdr.sgml : 20250729 20250729075824 ACCESSION NUMBER: 0001104659-25-071432 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250729 DATE AS OF CHANGE: 20250729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11960 FILM NUMBER: 251157612 BUSINESS ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA FORMER COMPANY: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 6-K 1 azn-20250630x6k.htm FORM 6-K ASTRAZENECA PLC_2025-06-30 ASTRAZENECA PLC 0000901832 6-K 2025-06-30 false --12-31 Q2 2025 P24M 0000901832 srt:EuropeMember azn:WainuaMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:VaccineAndInfectionMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:TruqapMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:TezspireMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:SaphneloMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:BeyfortusMember 2025-04-01 2025-06-30 0000901832 country:US azn:WainuaMember 2025-04-01 2025-06-30 0000901832 country:US azn:VaccineAndInfectionMember 2025-04-01 2025-06-30 0000901832 country:US azn:BeyfortusMember 2025-04-01 2025-06-30 0000901832 country:US azn:AirsupraMember 2025-04-01 2025-06-30 0000901832 azn:EstablishedRowMember azn:TruqapMember 2025-04-01 2025-06-30 0000901832 azn:EstablishedRowMember azn:FlumistMember 2025-04-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:TruqapMember 2025-04-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:TezspireMember 2025-04-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:SaphneloMember 2025-04-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:EnhertuMember 2025-04-01 2025-06-30 0000901832 azn:WainuaMember 2025-04-01 2025-06-30 0000901832 azn:FlumistMember 2025-04-01 2025-06-30 0000901832 azn:BeyfortusMember 2025-04-01 2025-06-30 0000901832 azn:AirsupraMember 2025-04-01 2025-06-30 0000901832 srt:EuropeMember azn:WainuaMember 2025-01-01 2025-06-30 0000901832 srt:EuropeMember azn:TruqapMember 2025-01-01 2025-06-30 0000901832 srt:EuropeMember azn:TezspireMember 2025-01-01 2025-06-30 0000901832 srt:EuropeMember azn:SaphneloMember 2025-01-01 2025-06-30 0000901832 srt:EuropeMember azn:BeyfortusMember 2025-01-01 2025-06-30 0000901832 country:US azn:WainuaMember 2025-01-01 2025-06-30 0000901832 country:US azn:SymbicortMember 2025-01-01 2025-06-30 0000901832 country:US azn:AirsupraMember 2025-01-01 2025-06-30 0000901832 azn:EstablishedRowMember azn:TruqapMember 2025-01-01 2025-06-30 0000901832 azn:EstablishedRowMember azn:FlumistMember 2025-01-01 2025-06-30 0000901832 azn:EstablishedRowMember azn:BeyfortusMember 2025-01-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:WainuaMember 2025-01-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:TruqapMember 2025-01-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:TezspireMember 2025-01-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:SaphneloMember 2025-01-01 2025-06-30 0000901832 azn:EmergingMarketsMember azn:AirsupraMember 2025-01-01 2025-06-30 0000901832 azn:WainuaMember 2025-01-01 2025-06-30 0000901832 azn:TruqapMember 2025-01-01 2025-06-30 0000901832 azn:AirsupraMember 2025-01-01 2025-06-30 0000901832 ifrs-full:Level3OfFairValueHierarchyMember 2025-01-01 2025-06-30 0000901832 ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-06-30 0000901832 ifrs-full:AggregatedIndividuallyImmaterialBus